Key Highlight
Despite recent weakness and significant drawdown, a bullish MACD crossover suggests potential for short-term momentum recovery.
The company's stock is experiencing a bearish trend, trading below its 50-day and 200-day moving averages, with a negative trend alignment score of -3, suggesting a period of weakness. Despite this, momentum shows a mixed signal with a neutral RSI of 44.7 but a bullish MACD crossover, implying potential for a short-term reversal.
Recent quarterly results indicate a significant decline in profitability, with net profit falling by 50.185% quarter-over-quarter and 57.206% year-over-year, despite a marginal 0.014% increase in revenue year-over-year. This suggests underlying operational challenges impacting earnings.
Analysts maintain a predominantly positive outlook, with a total of 19 'Buy' or 'Strong Buy' recommendations out of 37 total ratings, although there has been a slight shift towards 'Hold' ratings over the past month, indicating a cautious optimism.
Institutional investors hold a majority stake of 54.38% in the company, with recent activity showing a decrease in Foreign Institutional Investor (FII) holdings by 0.61% and an increase in Domestic Institutional Investor (DII) holdings by 0.47% in the last quarter. This shift may reflect differing market views between domestic and foreign institutions.
The stock is trading significantly below its 52-week high, currently down by 25.91%, while remaining 3.37% above its 52-week low. This positioning highlights recent underperformance but also suggests it is not at its lowest point, potentially offering a recovery opportunity if market conditions improve.